The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I

Molecular Pharmacology

Volumn 57, Issue 3, 2000, Pages 619-624

  Johansson, Ann Sofie ^a   Ridderström, Marianne ^a   Mannervik, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; ENZYME INHIBITOR; GAMMA GLUTAMYL S BENZYLCYSTEINYLPHENYLGLYCINE; GLUTATHIONE TRANSFERASE; LACTOYLGLUTATHIONE LYASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DRUG RESISTANCE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034051074     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.3.619     Document Type: Article

References (52)

1. Ahmad H, Wilson DE, Fritz RR, Singh SV, Medh RD, Nagle GT, Awasthi YC and Kurosky A (1990) Primary and secondary structural analyses of glutathione S-transferase π from human placenta. Arch Biochem Biophys 278:398-408.
2. Ali-Osman F, Akande O, Antoun G, Mao J-X and Boulamwini J (1997) Molecular cloning, characterization and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J Biol Chem 15:10004-10012.
3. Aronsson A-C, Sellin S, Tibbelin G and Mannervik B (1981) Probing the active site of glyoxalase I from human erythrocytes by use of the strong reversible inhibitor S-p-bromobenzylglutathione and metal substitutions. Biochem J 197:67-75.
4. Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S and Niitsu Y (1996) Transfection of glutathione S-transferase (GST)-Pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide. Cancer Res 56:3577-3582.
5. Bardsley WG, Bukhari NAJ, Ferguson MWJ, Cachaza JA and Burguillo FJ (1995) Evaluation of model discrimination, parameter estimation and goodness of fit in nonlinear regression problems by test statistics distributions. Comput Chem 19: 75-84.
6. Berhane K, Widersten M, Engström Å, Kozarich JW and Mannervik B (1994) Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci USA 91:1480-1484.
7. Board PG, Webb GC and Coggan M (1989) Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53:205-213.
8. Cameron AD, Olin B, Ridderström M, Mannervik B and Jones TA (1997) Crystal structure of human glyoxalase I: Evidence for gene duplication and 3D domain swapping. EMBO J 16:3386-3395.
9. Cameron AD, Ridderström M, Olin B and Mannervik B (1999) Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue. Structure Folding Design 7:1067-1078.
10. Castro VM, Söderström M, Carlberg I, Widersten M, Platz A and Mannervik B (1990) Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione-linked enzymes. Carcinogenesis 11:1569-1576.
11. Ciaccio PJ, Tew KD and LaCreta FP (1990) The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun 2:279-286.
12. Cnubben NH, Rommens AJ, Oudshoorn MJ and Van Bladeren PJ (1998) Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells. Cancer Res 58:4616-4623.
13. Dirr H, Reinemer P and Huber R (1994) X-ray crystal structures of cytosolic glutathione S-transferases: Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem 220:645-661.
14. Dirven HA, Dictus EL, Broeders NL, Van Ommen B and Van Bladeren PJ (1995) The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa. Cancer Res 55:1701-1706.
15. Flatgaard JE, Bauer KE and Kauvar LM (1993) Isozyme specificity of novel glutathione-S-transferase inhibitors. Cancer Chemother Pharmacol 33:63-70.
16. Habig WH, Pabst MJ and Jakoby WB (1974) Glutathione S-transferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
17. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B and Ringborg U (1991) Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51:94-98.
18. Johansson A-S, Stenberg G, Widersten M and Mannervik B (1998) Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 278:687-698.
19. Kavarana MJ, Kovaleva EG, Creighton DJ, Wollman MB and Eiseman JL (1999) Mechanism-based competitive inhibitors of glyoxalase I: Intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. J Med Chem 42:221-228.
20. Kellum MW, Oray B and Norton SJ (1978) A convenient quantitative synthesis of methylglyoxal for glyoxalase I assays. Anal Biochem 85:586-590.
21. Kuzmich S, Vanderveer LA, Walsh ES, LaCreta FP and Tew KD (1992) Increased levels of glutathione S-transferase π transcript as a mechanism of resistance to ethacrynic acid. Biochem J 281:219-224.
22. Lyttle MH, Hocker MD, Hui HC, Caldwell CG, Aaron DT, Engqvist-Goldstein Å, Flatgaard JE and Bauer KE (1994) Isozyme-specific glutathione-S-transferase inhibitors: Design and synthesis. J Med Chem 37:189-194.
23. Mannervik B (1980) Glyoxalase I, in Enzymatic Basis of Detoxication (Jakoby WB ed) Vol 2, pp 263-273, Academic Press, New York.
24. Mannervik B, Ålin P, Guthenberg C, Jensson H, Tahir MK, Warholm M and Jörnvall H (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82:7202-7206.
25. Mannervik B, Castro VM, Danielson UH, Tahir MK, Hansson J and Ringborg U (1987) Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 8:1929-1932.
26. Mannervik B and Widersten M (1995) Human glutathione transferases: Classification, tissue distribution and functional properties, in Advances in Drug Metabolism in Man (Pacifici GM and Fracchia GN eds) pp 408-459, European Commission, Luxembourg.
27. Morgan AS, Ciaccio PJ, Tew KD and Kauvar LM (1996) Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol 37:363-370.
28. Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieland HS, O'Brien EE, Poplack DG, Cossman J, Myers CE and Cowan KH (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422-1428.
29. Norton SJ, Elia AC, Chyan MK, Gillis G, Frenzel C and Principato GB (1993) Inhibitors and inhibition studies of mammalian glyoxalase II activity. Biochem Soc Trans 21:545-548.
30. Oakley AJ, Lo Bello M, Battistoni A, Ricci G, Rossjohn J, Villar HO and Parker MW (1997) The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution. J Mol Biol 274:84-100.
31. O'Brien ML and Tew KD (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A:967-978.
32. 2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry 34: 648-655.
33. Racker E (1951) The mechanism of action of glyoxalase. J Biol Chem 190:685-696.
34. Ranganathan S, Walsh ES and Tew KD (1995) Glyoxalase I in detoxification: Studies using a glyoxalase I transfectant cell line. Biochem J 309:127-131.
35. Reinemer P, Dirr HW, Ladenstein R, Huber R, Lo Bello M, Federici G and Parker MW (1992) Three-dimensional structure of class π glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 Å resolution. J Mol Biol 227:214-226.
36. Ridderström M, Cameron AD, Jones TA and Mannervik B (1997) Mutagenesis of residue 157 in the active site of human glyoxalase I. Biochem J 328:231-235.
37. Ridderström M and Mannervik B (1996) Optimized heterologous expression of the human zinc enzyme glyoxalase I. Biochem J 314:463-467.
38. Ridderström M, Saccucci F, Hellman U, Bergman T, Principato G and Mannervik B (1996) Molecular cloning, heterologous expression, and characterization of human glyoxalase II. J Biol Chem 271:319-323.
39. Segel IH (1975) Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems pp 299-309, John Wiley and Sons, Inc., New York.
40. Sundberg K, Johansson A-S, Stenberg G, Widersten M, Albrecht S, Mannervik B and Jernström B (1998) Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19:433-436.
41. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313-4320.
42. Tew KD, Bomber AM and Huffman SJ (1988) Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48:3622-3625.
43. Thornalley PJ (1993) The glyoxalase system in health and disease. Mol Aspects Med 14:287-371.
44. Thornalley PJ (1995) Advances in glyoxalase research: Glyoxalase expression in malignancy, antiproliferative effects of methylglyoxal, glyoxalase inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor. Crit Rev Oncol Hematol 20:99-128.
45. Thornalley PJ, Edwards LG, Kang Y, Wyatt C, Davies N, Ladan MJ and Double J (1996) Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Biochem Pharmacol 51:1365-1372.
46. Tsuchida S and Sato K (1992) Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27:337-384.
47. Uotila L (1981) Thioesters of glutathione. Methods Enzymol 77:424-430.
48. Vander Jagt DL (1989) The glyoxalase system, in Coenzymes and Cofactors (Dolphin D, Poulson R and Avramovic O eds) Vol 3A, pp 597-641, John Wiley & Sons, New York.
49. Vince R and Daluge S (1971) Glyoxalase inhibitors: A possible approach to anticancer agents. J Med Chem 14:35-37.
50. Watson MA, Stewart RK, Smith GBJ, Massey TE and Bell DA (1998) Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275-280.
51. Whelan RDH, Waring CJ, Wolf CR, Hayes JD, Hoskings LK and Hill BT (1992) Over-expression of P-glycoprotein and glutathione S-transferase Pi in MCF-7 cells selected for vincristin resistance in vitro. Int J Cancer 52:241-246.
52. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S and Awasthi YC (1994) Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 105 differ in enzymic properties. Eur J Biochem 224:893-899.